510(k) K250499

RELiZORB (100300/100301) by Alcresta Therapeutics, Inc. — Product Code PLQ

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
April 17, 2025
Date Received
February 20, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Packed Cartridge
Device Class
Class II
Regulation Number
876.5985
Review Panel
GU
Submission Type

Hydrolyze fats in enteral formula.